Daewoong Pharmaceutical lowers earnings outlook as Pecsufly shifts to direct sales, target price down 4.8% [Why Bio]
Predicted impact: Medium· Actual: −10.0% vs sector, volume 1.1× normal (5 trading days)
Earnings outlook cut on Pecsufly sales shift; target down 4.8%.